The practical takeaway is this
But if you weight effectiveness as a function of risk/benefit, not just pigment density, the picture changes: a slightly milder tan produced by a more selective, clinically studied drug may be preferable to the dramatic but pharmacologically messy profile of Melanotan IIespecially when the latter is sourced from unregulated research chemical suppliers
Such carriers often require further functional integration, though, and mild, efficient, and noncovalent modifications are most suitable for ligand-engineered carriers
This strategy may help you control hunger, lose weight more consistently, and feel better overall when done safely and with expert support
Eli Lilly Lilly has stated it has "no data on the benefits or risks of microdosing tirzepatide" and does not recommend the practice